EVA CLARK to Rituximab
This is a "connection" page, showing publications EVA CLARK has written about Rituximab.
Connection Strength
0.265
-
The Importance of Early Recognition of KSHV-Mediated Syndromes: A Case Report. Am J Med. 2021 10; 134(10):e503-e506.
Score: 0.136
-
Convalescent plasma for persisting COVID-19 following therapeutic lymphocyte depletion: a report of rapid recovery. Br J Haematol. 2020 08; 190(3):e154-e156.
Score: 0.129